December 7-10, 2019 – Orange County Convention Center (OCCC), Orlando, FL
Poster Presentation – First-in-Human Study of ET019003, a Next Generation Anti-CD19 T-Cell Therapy, in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma (r/r DLBCL)
December 2-5, 2019 – San Francisco Airport Marriott Waterfront, San Francisco, CA
TCR-mimic Antibody Redirected T-cell Therapy for Solid Tumors
November 6-10, 2019 – Gaylord National Hotel & Convention Center, National Harbor, MD
Poster Presentation – ET140202 T-cell Therapy for the Treatment of Liver Cancer is Built upon a Novel Antibody-T cell Receptor (AbTCR) ARTEMIS” T-cell Platform
September 28, 2019 – Santa Clara Convention Center, Santa Clara, CA
Panel Discussion – The Promise of Cell Therapy
September 17-18, 2019 – Crowne Plaza San Francisco Airport, San Francisco, CA
Antibody-TCR (AbTCR) T-cell Therapy for Solid and Hematological Malignancies
September 10-13, 2019 – Seaport Hotel & WTC, Boston, MA
ET140202 T-Cell Therapy in Advanced Liver Cancer (Hepatocellular Carcinoma)
A Novel Antibody-T cell Receptor (AbTCR) ARTEMIS” T-cell Platform Designed to Prevent T-Cell Hyperactivation
June 18-20, 2019 – Shanghai, China
Antibody-TCR ARTEMIS” T-cell Therapy for Solid Tumors & Hematological Malignancies
June 18-20, 2019 – Park Central Hotel, San Francisco, CA
Safety and Efficacy of TCR-mimic Technology in Hematologic and Solid Tumors
May 13-17, 2019 – Encore Hotel, Las Vegas, NV
Antibody-TCR ARTEMIS” T-cell Therapy for Solid Tumors & Hematological Malignancies
April 16-17, 2019 – InterContinental Shanghai Ruijin Hotel, Shanghai, China
Antibody-TCR (AbTCR) T-cell Therapy for Solid and Hematological Malignancies
Alexa Willson has served as the Chief Financial Officer of Eureka Therapeutics since August 2022. Prior to joining the company, She was a Managing Partner of Cloudstone Venture Capital, an early-stage healthtech venture firm since October 2020. Cloudstone is also an investor of Eureka Therapeutics.
Ms. Willson has over 25 years of experience advising public and private companies on corporate finance, strategy, capital raising, valuation, mergers & acquisitions, and other matters. She has founded and run a midmarket investment banking boutique and worked with large Wall Street investment banks, including Kidder Peabody and Drexel Burnham.
Ms. Willson has served on private and non-profit boards and investment committees in various capacities. She teaches financial literacy. Ms. Willson holds a BA from Harvard and an MBA from Stanford Graduate School of Business.